{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:32:04Z","timestamp":1786375924986,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10928-026-10032-z","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:11:26Z","timestamp":1778958686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A missed synthesis from the 1930s: Teorell, Mayneord, and the origins of physiological PK\u2013TGI modelling"],"prefix":"10.1007","volume":"53","author":[{"given":"Hitesh B.","family":"Mistry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"4","key":"10032_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1158\/AJC.1932.841","volume":"16","author":"WV Mayneord","year":"1932","unstructured":"Mayneord WV (1932) On a law of growth of Jensen\u2019s rat sarcoma. Am J Cancer 16(4):841\u2013846. https:\/\/doi.org\/10.1158\/AJC.1932.841","journal-title":"Am J Cancer"},{"key":"10032_CR2","first-page":"205","volume":"57","author":"T Teorell","year":"1937","unstructured":"Teorell T (1937) Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration. Arch Int Pharmacodyn Ther 57:205\u2013225","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10032_CR3","first-page":"226","volume":"57","author":"T Teorell","year":"1937","unstructured":"Teorell T (1937) Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch Int Pharmacodyn Ther 57:226\u2013240","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"1","key":"10032_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/03009739509178895","volume":"100","author":"LK Paalzow","year":"1995","unstructured":"Paalzow LK (1995) Torsten Teorell, the father of pharmacokinetics. Ups J Med Sci 100(1):41\u201346. https:\/\/doi.org\/10.3109\/03009739509178895","journal-title":"Ups J Med Sci"},{"issue":"5","key":"10032_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.bulm.2003.11.002","volume":"66","author":"RP Araujo","year":"2004","unstructured":"Araujo RP, McElwain DLS (2004) A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull Math Biol 66(5):1039\u20131091. https:\/\/doi.org\/10.1016\/j.bulm.2003.11.002","journal-title":"Bull Math Biol"},{"issue":"5","key":"10032_CR6","first-page":"988","volume":"76","author":"VP Collins","year":"1956","unstructured":"Collins VP, Loeffler RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 76(5):988\u20131000","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"6","key":"10032_CR7","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/1097-0142(196111\/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H","volume":"14","author":"M Schwartz","year":"1961","unstructured":"Schwartz M (1961) A biomathematical approach to clinical tumor growth. Cancer 14(6):1272\u20131294. https:\/\/doi.org\/10.1002\/1097-0142(196111\/12)14:6%3C;1272::AID-CNCR2820140618%3E;3.0.CO;2-H","journal-title":"Cancer"},{"key":"10032_CR8","first-page":"190","volume-title":"Cell Proliferation","author":"ML Mendelsohn","year":"1963","unstructured":"Mendelsohn ML (1963) Cell proliferation and tumour growth. In: Lamerton LF, Fry RJM (eds) Cell Proliferation. Blackwell Scientific, Oxford, pp 190\u2013210"},{"issue":"3","key":"10032_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/bjc.1964.55","volume":"18","author":"AK Laird","year":"1964","unstructured":"Laird AK (1964) Dynamics of tumor growth. Br J Cancer 18(3):490\u2013502. https:\/\/doi.org\/10.1038\/bjc.1964.55","journal-title":"Br J Cancer"},{"issue":"4","key":"10032_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/sapm1972514317","volume":"51","author":"HP Greenspan","year":"1972","unstructured":"Greenspan HP (1972) Models for the growth of a solid tumor by diffusion. Stud Appl Math 51(4):317\u2013340. https:\/\/doi.org\/10.1002\/sapm1972514317","journal-title":"Stud Appl Math"},{"issue":"1","key":"10032_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/imammb\/14.1.39","volume":"14","author":"JP Ward","year":"1997","unstructured":"Ward JP, King JR (1997) Mathematical modelling of avascular-tumour growth. IMA J Math Appl Med Biol 14(1):39\u201369. https:\/\/doi.org\/10.1093\/imammb\/14.1.39","journal-title":"IMA J Math Appl Med Biol"},{"key":"10032_CR12","doi-asserted-by":"publisher","first-page":"17992","DOI":"10.1038\/srep17992","volume":"5","author":"Y Chen","year":"2015","unstructured":"Chen Y, Wang H, Zhang J, Chen K, Li Y (2015) Simulation of avascular tumor growth by agent-based game model involving phenotype-phenotype interactions. Sci Rep 5:17992. https:\/\/doi.org\/10.1038\/srep17992","journal-title":"Sci Rep"},{"key":"10032_CR13","doi-asserted-by":"publisher","first-page":"e6983","DOI":"10.7717\/peerj.6983","volume":"7","author":"D Orrell","year":"2019","unstructured":"Orrell D, Mistry HB (2019) A simple model of a growing tumour. PeerJ 7:e6983. https:\/\/doi.org\/10.7717\/peerj.6983","journal-title":"PeerJ"},{"key":"10032_CR14","doi-asserted-by":"publisher","first-page":"e10681","DOI":"10.7717\/peerj.10681","volume":"9","author":"J Dickinson","year":"2021","unstructured":"Dickinson J, de Matas M, Dickinson PA, Mistry HB (2021) Exploring a model-based analysis of patient derived xenograft studies in oncology drug development. PeerJ 9:e10681. https:\/\/doi.org\/10.7717\/peerj.10681","journal-title":"PeerJ"},{"issue":"2","key":"10032_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10928-023-09891-7","volume":"51","author":"HJ Huber","year":"2024","unstructured":"Huber HJ, Mistry HB (2024) Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model. J Pharmacokinet Pharmacodyn 51(2):169\u2013185. https:\/\/doi.org\/10.1007\/s10928-023-09891-7","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"10032_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10928-010-9156-2","volume":"37","author":"NL Jumbe","year":"2010","unstructured":"Jumbe NL, Xin Y, Leipold DD, Crocker L, Dugger D, Mai E et al (2010) Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice. J Pharmacokinet Pharmacodyn 37(3):221\u2013242. https:\/\/doi.org\/10.1007\/s10928-010-9156-2","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"10032_CR17","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.cmpb.2013.06.014","volume":"114","author":"ND Evans","year":"2014","unstructured":"Evans ND, Dimelow RJ, Yates JWT (2014) Modelling of tumour growth and cytotoxic effect of docetaxel in xenografts. Comput Methods Programs Biomed 114(3):e3\u2013e13. https:\/\/doi.org\/10.1016\/j.cmpb.2013.06.014","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"10032_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/0008-5472.CAN-03-2524","volume":"64","author":"M Simeoni","year":"2004","unstructured":"Simeoni M, Magni P, Cammia C, De Nicolao G, Croci V, Pesenti E et al (2004) Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res 64(3):1094\u20131101. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-2524","journal-title":"Cancer Res"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10032-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10032-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10032-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:25:49Z","timestamp":1786375549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-026-10032-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10032"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10032-z","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27"}}